News Center

Home page

Peak Report

News reports

Meet the challenge at the peak

Release time:

2020-08-14

Meeting Challenges at Peak

■ Peak Pharmaceutical Zhang Mingyin

came to Peak Pharmaceutical Company from 2010 5# November. It has been eight years in an instant. In the past eight years, for me, four words can be summed up, that is, "learning while doing", constantly enriching myself and challenging myself.

My first position in a pharmaceutical company was in the quality assurance department. I still remember the first time I reported to the central laboratory, and the director asked me, "What did I do before?" I answered, "Workshop production management." The director said, "You should follow Xu Lizhen first when you go to work tomorrow..." In this way, Xu Lizhen, a small girl with serious and meticulous work, became my first master in the peak. Under her guidance, I started with the most basic physical and chemical tests and really started from scratch. It was midsummer, 10ml control bottle sampling, we climbed up and down the warehouse busy, everyone is a big sweat. By the end of summer, I was transferred to the then Jiangnan factory for process verification. The new master Qian Shenghua was a muscular boy like Tai Sen, but his work was still as meticulous and serious. Now, my two "little masters" have reached management positions, and batch after batch of young people have been continuously enriched to key positions. From them, I feel the tolerance and trust of the peak corporate culture, and also feel 60 -year-old peak full of vitality.

Working on intellectual property was another major challenge I took on at Spike Pharmaceuticals. In 2012 , I took over the related patent application maintenance and other intellectual property work originally undertaken by the Production Technology Department. In order to do this work well, In 2013 , I obtained the first intellectual property internal auditor qualification certificate from a pharmaceutical company, laying the foundation for a series of follow-up work. In 2014 , the trademark work of the former market planning department was also merged. The pharmaceutical company set up an intellectual property department and actively introduced the enterprise intellectual property management system. The burden on my shoulders became heavier and heavier. With the support and help of leaders and colleagues from various departments, in 2015 , Jianfeng Pharmaceutical's first company intellectual property management manual was completed and issued. 2016 successfully passed the third-party certification of the enterprise's intellectual property management system and was recognized as a national intellectual property advantage enterprise; In March of the same year 9, pharmaceutical Company No. 1050800 "Peak" Trademark (Class 5 ) was recognized as a well-known trademark in China by the State Administration for Industry and Commerce. In 2017 , Jianfeng Pharmaceutical won the honorary title of National Intellectual Property Demonstration Enterprise. This is the highest-level honor for national intellectual property work. When I heard this news, don't mention how proud I was.

In fact, before I took over, Jianfeng Pharmaceutical's intellectual property work had a very solid foundation. As early as

2012 , we were rated as Jinhua patent demonstration enterprise, and 2013 became Zhejiang patent demonstration enterprise. With this foundation, the subsequent implementation and benchmarking work also came naturally. At the same time, in the process of standardization, our relevant management became more standardized and orderly, and the level of intellectual property work has made great progress. As a specific participant in this work, I not only experienced my personal growth, but also gained several "firsts": 2015 , won the title of "advanced worker" for the first time; this year, it was recommended by Jinhua Municipal Science and Technology Bureau as an advanced individual of national intellectual property work enterprises.

Looking back at the peak of eight years, I deeply realize that here, we can have the opportunity to learn, have the opportunity to create, and have the opportunity to realize the integration of personal value and enterprise. This year, the 60th anniversary of Jianfeng Group's establishment and the 20th anniversary of the establishment of the pharmaceutical company. The eight years I have experienced are only a short part of the peak process. I did not have the opportunity to participate in the earlier past, but in the next ten years, I will be with the peak. With the same, I will confidently contribute my strength to the more brilliant peak

70rd anniversary.

More information

Shanghai Bronze Award for Outstanding Invention Went in North Carolina

News from this newspaper The results of the 31st Shanghai Excellent Invention Trial jointly organized by the Shanghai Federation of Trade Unions, Shanghai Intellectual Property Office, Shanghai Municipal Committee of the Communist Youth League, Shanghai Science and Technology Association, and Shanghai Invention Association were evaluated a few days ago. The "Quality Improvement and Industrialization Optimization of Erlotinib Hydrochloride and Its Advanced Intermediates" declared by Technology Co., Ltd. won the bronze award. Erlotinib hydrochloride is a targeted therapy drug for the treatment of non-small cell lung cancer, which can prolong the survival time and improve the quality of life of lung cancer patients. It can target and specific sites of action to kill tumor cells, and has little impact on normal tissues. It belongs to the biological and new medical technology in the field of high-tech supported by the state. In this invention, 6,7-dimethoxyquinazoline -4-one, 4-chloro -6,7-di (2-methoxyethoxy) quinazoline and 3-aminophenylacetylene are important intermediates of erlotinib hydrochloride, which is also an important intermediate of icotinib hydrochloride, the first new anti-tumor drug of tinib in China. The invention designs and adopts a new synthesis process route, which can effectively reduce the cost of raw materials, the reactions are mostly aqueous phase reactions, energy consumption and three waste emissions are reduced by about 35%, industrialization conditions are optimized, product quality is improved, and it is applied to Industrialized mass production is conducive to the production of high-quality and low-cost erlotinib hydrochloride drugs and reduces the economic burden of patients. The Shanghai Excellent Invention Trial was founded in 1987. It is an important science and technology award approved by the Shanghai Municipal Government. It not only strongly promoted the majority of employees to carry out invention and creation activities based on their posts, but also improved the order.

2020

07-31

Jiang Xiaomeng Selected as Top Ten News Figures in Building Materials Industry Interview with China Building Materials Magazine in August

Jiang Xiaomeng was selected as one of the top ten news figures in the building materials industry. "China Building Materials" magazine published an exclusive interview in August. The 8th issue of 2019 "China Building Materials" magazine published a few days ago. In the "Exclusive Perspective" column, it published an exclusive interview with Jiang Xiaomeng, the top ten news figures in the building materials industry in 2018, the party secretary and chairman of the group company. The selection of the top ten news figures in the national building materials industry initiated by "China Building Materials" magazine has established nearly a hundred shining figures in the industry since 1999, which has attracted widespread attention in the industry. The selection of the top ten news figures in the building materials industry in 2018 is described as follows: Jiang Xiaomeng is a scholar and practical outstanding entrepreneur. In 2018, with his strategic thinking of insight into the future, he united and led cadres and employees at all levels of Jianfeng Group to actively adapt to the new economic normal, focusing on deepening supply-side structural reforms, the "Belt and Road" initiative, and vigorously advocating corporate transformation and upgrading and high-quality development. Work, seize opportunities, reform and innovate, and achieve historic new achievements in the development of the peak 60 years. The group's overall economic efficiency and development quality have been significantly improved. In recent years, under the leadership of Jiang Xiaomeng, Jianfeng Group has seized the opportunity to join forces with central enterprises to participate in the establishment of Southern Cement, effectively integrate the cement market in Zhejiang Province, optimize the allocation of cement industry resources, and greatly improve social and economic benefits. It has a positive and far-reaching impact on the supply-side structural reform and healthy development of the cement industry in Zhejiang Province. At the same time, the long-term layout of the peak group, strategically predict the direction of national development.

2020

07-31

To live up to the mission and realize the dream of a century-Jiang Xiaomeng, Party Secretary and Chairman of Zhejiang Jianfeng Group Co., Ltd., Top Ten News Figures in Building Materials Industry in 2018

Jianfeng Group started from a small cement plant with an annual output of 30000 tons in 1958. Through horizontal alliance with township enterprises, the formation of enterprise groups and the implementation of joint-stock reform, Jianfeng Group took the lead in listing in China's cement industry in 1993 and explored diversified operation. In 2007, Jianfeng joined hands with the central enterprise China Building Materials to participate in the establishment of Southern Cement, which strategically shifted the focus of the cement industry, and at the same time through enterprise mergers and technological innovation, the pharmaceutical industry is growing rapidly ...... Such a long history, in the industry has a good reputation of enterprises, Zhejiang Province, the earliest existing listed companies, its head is Jiang Xiaomeng. Focus on Industry Jiang Xiaomeng has spent nearly 40 years in Jinhua Cement Factory, the predecessor of Jianfeng Group. As a witness and promoter of the development and growth of the peak, Jiang Xiaomeng said that the sustained and steady development of the peak group benefits from the long-term focus on industry, which is the value orientation of the peak and the responsibility of the enterprise. Whether there was only a single cement industry in the early stage or the diversified development after listing, all the investment projects of the peak have not left the industry. With the continuous emergence of new economic formats, many people once suggested that the peak should be transferred to the "fashionable" and rewarding industries such as the Internet, but they were all rejected. Jiang Xiaomeng explained that it is necessary to use professional people to do professional things. Peak's years of experience, talents, and resource accumulation are all in industry. Although the new format is good, it is not necessarily suitable for peak development. Take cement as an example, even in the case of peak pharmaceutical has occupied the group.

2020

07-31

Jiang Xiaomeng Selected as Top Ten News Figures in Building Materials Industry Interview with China Building Materials Magazine in August

2020

07-31

Jiang Xiaomeng Selected as Top Ten News Figures in Building Materials Industry Interview with China Building Materials Magazine in August

2020

07-30

The company held the first half of the board of directors, the board of supervisors half-year performance hit a record high

On August 29, the group company held the 11th meeting of the 10th board of directors of the company by means of communication, and deliberated and passed the semi annual report of Jianfeng group in 2019 and the amendment of internal control system of the company. In the first half of the year, the company focused on the general work policy of "innovation and reform, integration and improvement, scientific layout, and steady development", grasping the opportunities brought by economic structure optimization and industrial upgrading externally, continuously integrating resources internally, and improving the internal management system. Improve the efficiency of enterprise operation. In the first half of 2019, the company achieved total operating income of 1.686 billion billion yuan, an increase of 12.17 percent over the same period last year, and the net profit attributable to the owners of the parent company was 0.476 billion billion yuan, an increase of 57.55 percent over the same period last year. At the end of June 2019, the Company's total assets were $5.383 billion, up 9.82 from the beginning of the year, and its net assets were $3.817 billion, up 10.64 from the beginning of the year. In the first half of the year, the company made a new breakthrough in the expansion of cement business. The group company has completed the acquisition of 100 equity of Guizhou huangpinggu longmingchuan cement co., ltd. and continues to invest in the construction of its new dry cement production line with a daily output of 4500 tons of cement clinker (with waste heat power generation). Yunnan Jianfeng invested 5 million yuan to participate in the establishment of Yunnan Jianfeng Da Zhan Cement Co., Ltd., which plans to build a cement clinker production line in lameng county, Xishuangxian Dai autonomous prefecture by capacity replacement according to relevant national policies. The company's cement subsidiaries continue to carry out in-depth "three down three improve" activities, stable.

2020

07-31

< 1...28 29 30...61 > 跳转到页